Middle Meningeal Artery Embolization for Patients With Chronic Subdural Hematoma

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
COMPLEMENT study (ChrOnic subdural hematoMa Patients suppLemented with Embolization of Middle mENingeal artery Trial) is a prospective, open label, blinded endpoint (PROBE), Japanese, two-arm, randomized, controlled, post-market study to assess the efficacy and safety of middle meningeal artery embolization for chronic subdural hematoma.
Epistemonikos ID: 6c35c30e8f66728df5d600bf1802f7925fbfabc1
First added on: Feb 01, 2025